ctrl K

Price Alert

Acrivon Therapeutics Inc.... (ACRV)

NASDAQ: ACRV · Real-Time Price · USD

1.40

0.05 (3.70%)

At close: Aug 18, 2025, 3:59 PM

1.44

3.23%

Pre-market: Aug 19, 2025, 05:10 AM EDT

Acrivon Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	39.82M	36.02M	29.52M	99.6M
Short-Term Investments	139.66M	91.44M	98.23M	n/a
Long-Term Investments	5.09M	414K	41.88M	388K
Other Long-Term Assets	1.84M	251K	4.73M	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.15M	2.23M	4.34M	n/a
Total Current Assets	181.63M	129.69M	132.09M	100.41M
Property-Plant & Equipment	8.03M	7.91M	6.86M	5.79M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.96M	8.57M	53.48M	6.18M
Total Assets	196.59M	138.26M	181.23M	106.59M
Account Payables	758K	5.05M	904K	964K
Deferred Revenue	n/a	n/a	69K	66K
Short-Term Debt	1.06M	n/a	726K	664K
Other Current Liabilities	5.46M	3.52M	1.94M	-111K
Total Current Liabilities	17.21M	13.3M	6.52M	2.91M
Long-Term Debt	n/a	n/a	n/a	122.52M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.59M	3.77M	4.24M	127.48M
Total Liabilities	19.8M	17.07M	10.75M	130.4M
Total Debt	3.65M	4.64M	4.96M	5.63M
Common Stock	31K	23K	22K	2K
Retained Earnings	-196.98M	-116.42M	-56.03M	-24.86M
Comprehensive Income	447K	-83K	-95K	n/a
Shareholders Equity	176.79M	121.19M	170.47M	-23.81M
Total Investments	144.75M	91.86M	140.11M	388K